Sirona Biochem Corp V.SBM

Open Letter to Management

[forhandlaren]

Dear Management,

The closing price for 2021 was 0.175 compared to 0.325 in 2020 (and 0.440 in 2019). Do you consider this a severe problem or not?!

- street cred has been gained with the R+F deal
- cash flow (should have been much better if you had brought Linda Pullan to the R+F table)
- ongoing negotiations for a global TFC 1067 deal
- ongoing in-vitro for antiviral to jump on the COVID-19 commercial train
- anti-aging is approaching clinical trial - that will compete with Botox

There's so many commercial opportunities, but the share price reflect that the investor community doesn't expect any substantial value to be added. I think this is a severe problem - do you agree or not? 

It's not so much about finally close the TFC 1067-deal, but rather that trust has been eroded along the way. The expectations among investors are next to none. The low activity on this bullboard also reflect the interest in the company.

If you actually care about maximizing shareholder value, please use part of the payment to appoint another CEO - like it or not - that would probably double the share price overnight.

[doonery]

VERY WELL SAID,,FORHANDLAREN .A REPLY FROM MANAGEMENT IS REQUIRED .,BUT PROBABLY  NOT FORTHCOMING.WELCOME ALL TO  2022.THIS IS THE YEAR,BOOM OR BUST.

[lscfa]

In the long run we are all dead - John Maynard Keynes

[biorun]

1. Any manoeuvre or deal that brings it closer to either division into two companies (pharma and cosmetics) or buyout, should move the discontent with the ceo forward to a more logical resolution.  2. The stock is cheap again. It was cheap at 14-15, its cheap again going right out of the gate for 2022. Now that Linda is on board, the forthcoming deal development should bring a significantly

[Tickel1st]

This post has been removed in accordance with Community Policy

[gossamer4]

This post has been removed in accordance with Community Policy

[forhandlaren]

To be clear. There is an imminent need to build trust on which expectations can be established. The share price always reflects current state of the investor community. Seems like nobody cares about the business opportunities in the near future and I consider this to be unhealthy for a company. It's much better to overdeliver than overpromise. Since the latter has been the trademark of the

[forhandlaren]

Theory put into practise. The next announcement regarding a TFC-1067 deal - will that be a term sheet or the real deal? We know that the process has been communicated between the parties. Shouldn't jeopardize the business by communicate to the shareholders what to expect. In the new era the shareholders must be considered partners instead of just milk cows. I suspect that management

[bazooka73]

Absolutely agree with your  statements. At least bringing in additional competencies into the BoD (why not Linda Pullan) would massivly improve this terrible situation. Unfortunately, the company for a long time does not meet the minimum requirements for good gonvernance. It's ridiculous for a publicly traded company to have a executive management which is concruent to the BoD. Both 

[Transperance]

Forhandlaren, We have been given Howard the benefit of the doubt for so many years, but it has been in vain. As stated earlier, HR is a risk area and we, but also Howard, would not like to on-board a new Attila. But I certainly hope that Howard is clever enough to act on the CEO issue when/if a deal can be settled. However, in order to attract the right candidate, such a recruitment should be